Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 1
2013 2
2014 2
2015 2
2016 3
2017 4
2018 1
2019 5
2020 6
2021 6
2022 9
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer.
Blenman KRM, Marczyk M, Karn T, Qing T, Li X, Gunasekharan V, Yaghoobi V, Bai Y, Ibrahim EY, Park T, Silber A, Wolf DM, Reisenbichler E, Denkert C, Sinn BV, Rozenblit M, Foldi J, Rimm DL, Loibl S, Pusztai L. Blenman KRM, et al. Among authors: marczyk m. Clin Cancer Res. 2022 Jun 13;28(12):2587-2597. doi: 10.1158/1078-0432.CCR-21-3215. Clin Cancer Res. 2022. PMID: 35377948 Free PMC article. Clinical Trial.
Cancer Relevance of Human Genes.
Qing T, Mohsen H, Cannataro VL, Marczyk M, Rozenblit M, Foldi J, Murray M, Townsend JP, Kluger Y, Gerstein M, Pusztai L. Qing T, et al. Among authors: marczyk m. J Natl Cancer Inst. 2022 Jul 11;114(7):988-995. doi: 10.1093/jnci/djac068. J Natl Cancer Inst. 2022. PMID: 35417011
GaMRed-Adaptive Filtering of High-Throughput Biological Data.
Marczyk M, Jaksik R, Polanski A, Polanska J. Marczyk M, et al. IEEE/ACM Trans Comput Biol Bioinform. 2020 Jan-Feb;17(1):149-157. doi: 10.1109/TCBB.2018.2858825. Epub 2018 Jul 23. IEEE/ACM Trans Comput Biol Bioinform. 2020. PMID: 30040660
Comprehensive Analysis of Metabolic Isozyme Targets in Cancer.
Marczyk M, Gunasekharan V, Casadevall D, Qing T, Foldi J, Sehgal R, Shan NL, Blenman KRM, O'Meara TA, Umlauf S, Surovtseva YV, Muthusamy V, Rinehart J, Perry RJ, Kibbey R, Hatzis C, Pusztai L. Marczyk M, et al. Cancer Res. 2022 May 3;82(9):1698-1711. doi: 10.1158/0008-5472.CAN-21-3983. Cancer Res. 2022. PMID: 35247885
Diverse immune response of DNA damage repair-deficient tumors.
Qing T, Jun T, Lindblad KE, Lujambio A, Marczyk M, Pusztai L, Huang KL. Qing T, et al. Among authors: marczyk m. Cell Rep Med. 2021 May 18;2(5):100276. doi: 10.1016/j.xcrm.2021.100276. eCollection 2021 May 18. Cell Rep Med. 2021. PMID: 34095878 Free PMC article.
Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer.
Foldi J, Silber A, Reisenbichler E, Singh K, Fischbach N, Persico J, Adelson K, Katoch A, Horowitz N, Lannin D, Chagpar A, Park T, Marczyk M, Frederick C, Burrello T, Ibrahim E, Qing T, Bai Y, Blenman K, Rimm DL, Pusztai L. Foldi J, et al. Among authors: marczyk m. NPJ Breast Cancer. 2022 Feb 3;8(1):17. doi: 10.1038/s41523-022-00392-3. NPJ Breast Cancer. 2022. PMID: 35115541 Free PMC article. No abstract available.
42 results